Erasca, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ERAS Nasdaq 2836 www.erasca.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Erasca, Inc.

Erasca (ERAS) Stock Looks Overvalued On Price But Strong On Returns - Jul 15th, 2026 9:24 pm
Erasca Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares - Jul 15th, 2026 2:01 pm
Erasca (ERAS) Trial Update Draws Fresh Focus, Is The Valuation Already Full? - Jul 15th, 2026 9:13 am
Erasca (ERAS) Is Up 6.2% After Advancing ERAS-0015 Toward Registration Trials In RAS Cancers - Jul 15th, 2026 8:10 am
Erasca (ERAS) Surges 8.9% on Encouraging Cancer Trial Results - Jul 14th, 2026 5:40 pm
Erasca Announces Pricing of Upsized Public Offering of Common Stock - Jul 13th, 2026 9:10 pm
Erasca Announces Proposed Public Offering of $500 Million of Common Stock - Jul 13th, 2026 2:19 pm
Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors - Jul 13th, 2026 2:01 pm
Robinhood and 4 More Stocks That Were Just Added to This Firm’s ‘Top Picks’ List - Jul 2nd, 2026 12:44 pm
Tango Therapeutics Rides a New Precision Oncology Trend in 2026 - Jul 2nd, 2026 8:50 am
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026? - Jul 2nd, 2026 8:46 am
TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts - Jul 2nd, 2026 8:43 am
Verastem Says VS-7375 Trial Data Shows Anti-Tumor Activity in Advanced Solid Tumors - Jun 23rd, 2026 2:44 pm
Erasca (ERAS) Receives Encouraging Expert Feedback on ERAS-0015 Clinical Trials - Jun 11th, 2026 4:20 am
TNGX Stock Jumps 53% on Early Pancreatic Cancer Study Results - Jun 9th, 2026 10:44 am
Erasca (ERAS) Is Down 13.4% After IP Challenge to ERAS-0015 Trade Secrets and Patents - Jun 8th, 2026 10:12 am
Erasca Inc. (ERAS) Inspiring Confidence Through Commercial Collaborations - Jun 5th, 2026 9:55 am
Erasca Sees More Balanced Outlook as Early RAS Data Support Clinical Activity, BofA Says - Jun 4th, 2026 8:49 am
Here is Why Erasca (ERAS) is One of the Best Growth Stocks Under $20 - Jun 3rd, 2026 11:59 am
Why This Fund Made a $189 Million Bet on Erasca as Shares Skyrocket 800% - May 29th, 2026 6:47 pm